American College for Advancement in Medicine
ACAM Affirms Commitment to Trial to Assess Chelation Therapy
Published in Cardiovascular Device Liability Week, June 15th, 2008
The American College for Advancement in Medicine, ACAM, today reaffirmed its commitment to the Trial to Assess Chelation Therapy (TACT) currently in progress by the National Institute of Health (NIH). The goal of the study is to test whether chelation therapy and/or high-dose vitamin therapy is effective for the treatment of heart disease. Chelation therapy is a process in which a synthetic or man-made amino acid called EDTA is delivered intravenously.
ACAM has played a strategic role in disseminating information about the trial, linking participants to study-sites, and providing information to its members and the public about this important study. Today, ACAM...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Blue Shield of California Foundation
Blue Shield of California Foundation Awards $12.3 Million: Community Clinics and Domestic Violence Shelters Top List of Recipients - Patents
Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit - Abdominal Aortic Aneurysm
Findings from University of Cambridge in abdominal aortic aneurysm reported - Abdominal Aortic Aneurysm
New findings reported from D. Paolini and co-authors describe advances in abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Reports from Aragon Institute of Engineering Research highlight recent research in abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Scientists at Baptist Cardiac and Vascular Institute target abdominal aortic aneurysm - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
